232 US specialists provided feedback on their use and perceptions of biosimilar agents and their impact on the total treatment...
Nephrologists and rheumatologists are approaching the new products from very different perspectives EXTON, Pa., June 17, 2022 /PRNewswire/ —With the approvals...
Rheumatologists are more likely than PsA-treating dermatologists to cycle TNFs prior to introducing an alternative mechanism of action agent EXTON,...
The project is designed to explore to what degree the next generation of specialists are prepared to enter clinical practice...
Almost half, 49 percent, of rheumatologists, decreased prescriptions of Xeljanz over the past three months, according to Spherix Global Insights’...
As drugs in psoriasis and psoriatic arthritis therapy areas nab new indications that crisscross the two categories, dermatologists and rheumatologists...
The safety signals for cardiovascular events and malignancy associated with Janus kinase inhibitors in rheumatoid arthritis have led to rheumatologists...
Bristol Myers Squibb is the surprise winner in an emerging rheumatoid arthritis (RA) market dynamic as doctors eschew new JAK...
Potential paradigm shifts in the post-TNF and later-line setting leave ample opportunity for alternate mechanism agents EXTON, Pa., April 6,...
450 US specialists provided feedback on their use and perceptions of biosimilar agents and their impact on the total treatment...
New launch tracking reports and patient audit data show early excitement and ample opportunity for the latest approvals as well...
By: Eric John Pandemic aside (if you can imagine that), launching a drug in the pharmaceutical industry is no walk...
